Dermatology And Therapy

Journal Title：Dermatology And Therapy

Dermatology and Therapy is an international, open access, peer-reviewed, rapid publication journal (peer review in 2 weeks, published 3–4 weeks from acceptance). The journal is dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of dermatological therapies. Studies relating to diagnosis, pharmacoeconomics, public health and epidemiology, quality of life, and patient care, management, and education are also encouraged.

Areas of focus include, but are not limited to all clinical aspects of dermatology, such as skin pharmacology; skin development and aging; prevention, diagnosis, and management of skin disorders and melanomas; research into dermal structures and pathology; and all areas of aesthetic dermatology, including skin maintenance, dermatological surgery, and lasers.

The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports/case series, trial protocols, and short communications. Dermatology and Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an International and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of quality research, which may be considered of insufficient interest by other journals. The journal appeals to a global audience and receives submissions from all over the world.

《皮膚病學與治療學》是一本國際性、開放獲取、同行評審、快速出版的期刊（同行評審 2 周，接受后 3-4 周內出版）。該期刊致力于發(fā)表圍繞皮膚病學療法的發(fā)現(xiàn)、開發(fā)和使用的高質量臨床（所有階段）、觀察性、真實世界和健康結果研究。還鼓勵與診斷、藥物經濟學、公共衛(wèi)生和流行病學、生活質量以及患者護理、管理和教育相關的研究。

重點領域包括但不限于皮膚病學的所有臨床方面，例如皮膚藥理學；皮膚發(fā)育和衰老；皮膚病和黑色素瘤的預防、診斷和管理；皮膚結構和病理學研究；以及美容皮膚科的所有領域，包括皮膚保養(yǎng)、皮膚外科和激光。

該期刊受到廣大醫(yī)藥和醫(yī)療保健專業(yè)人士的關注，并發(fā)表原創(chuàng)研究、評論、病例報告/病例系列、試驗方案和簡短通訊。皮膚病學和治療學將考慮所有科學合理的研究，無論是正面、確認性還是負面數(shù)據(jù)。無論投稿涉及國際和/或特定國家的受眾，我們都歡迎投稿，當研究人員試圖針對更具體的患者群體時，這一點至關重要。這種包容性方法使該期刊能夠協(xié)助傳播其他期刊可能認為不夠有趣的高質量研究。該期刊吸引了全球讀者，并收到來自世界各地的投稿。

Dermatology And Therapy創(chuàng)刊于2011年，由Springer Healthcare出版商出版，收稿方向涵蓋Medicine - Dermatology全領域，此刊是中等級別的SCI期刊，所以過審相對來講不是特別難，但是該刊專業(yè)認可度不錯，仍然是一本值得選擇的SCI期刊 。平均審稿速度 6 Weeks ，影響因子指數(shù)3.5，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。